Nalu Medical competitors

D. Keith Grossman was named CEO and President of Nevro in March of 2019. Mr. Grossman has over 30 years of experience in the medical device field. He served most recently, and for the second time, as the President, Chief Executive Officer and director of Thoratec Corporation, leading up to its 2015 sale to St. Jude Medical. Prior to Thoratec, he served as President, Chief Executive Officer and director of Conceptus, a women’s health medical device company, leading up to its sale to Bayer Healthcare. Prior to Conceptus, Mr. Grossman served as managing director of TPG (Texas Pacific Group), a private equity firm, as a member of its healthcare investment team. Prior to TPG, Mr. Grossman served as Thoratec’s President, Chief Executive Officer and director for the first ten years of its growth as a commercial company. Mr. Grossman currently serves as Vice Chairman of Alcon, Inc., Chairman of Outset Medical, Inc. (privately held), and Board member of ViewRay, Inc. and previously served as a member of the Board of directors of Intuitive Surgical, Inc., Kyphon, Inc., and a number of privately held medical device companies. Mr. Grossman received a B.S. in life sciences from The Ohio State University and an M.B.A. from Pepperdine University.

Fred B Parks is a Board Member at Steady State Imaging LLC, Board Member at Nuvectra, and Chief Executive Officer at Nuvectra. He has worked as President/COO at ST JUDE MEDICAL INC, Chief Executive Officer at NDS Surgical Imaging, and Board Member at VIASYS HEALTHCARE INC.. Fred works or has worked as Board Member at Enovate Medical, LLC and Board Member at NDS Surgical Imaging. He studied at University of Missouri-Columbia and University of Arizona.

Richard 'Rich' Mott is a Chairman at Conventus Orthopaedics Inc, President/CEO at Kyphon, and Board Member at Vertiflex. He has worked as Board Member at Alfred University, Board Member at Conventus Orthopaedics Inc, and VP/General Manager at Greatbatch Scientific. Richard attended Alfred University and Harvard University.

Maria E. Bennett has led SPR Therapeutics since its inception. Prior to the formation of SPR, Maria Bennett served as the VP of Clinical Affairs at NDI Medical, LLC a medical device development company where she played a vital role in the development of a neurostimulation system addressing urinary incontinence, which was acquired by Medtronic in 2008 company for $42 million. Prior to joining NDI, Maria Bennett was a Clinical Project Manager at Boston Scientific, leading a team that conducted a large, multi-center clinical trial demonstrating safety and efficacy of an innovative angioplasty balloon, and achieving a 510(k) clearance for this product. Prior to this, she was the Manager of Clinical Studies and Director of Research and Development at NeuroControl Corp., where she co-developed a neurostimulation treatment for post-stroke shoulder pain. In 2009, she was selected by Springboard Enterprises as one of thirty female entrepreneurs from over 100 applicants to present at its LifeScience Venture Forums. She is the inventor of the Smartpatch™ System, having patents issued and pending. Maria Bennett holds a master's degree in biomedical engineering from Case Western Reserve University and a bachelor's degree from Miami University (OH) in engineering management.

Seasoned medical device executive with substantial experience in European commercialization and PMA devices. Have led both a private, venture-backed company (Sequent) and a publicly-traded company (MicroTherapeutics) to successful exits. Experience consists of an eleven-year stint at Medtronic, including six years in Europe and Asia, followed by fourteen years as CEO of both private and public companies.